Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

RSS icon
Thumbnail

Visualization dashboards for EHR data improve situational awareness, decrease errors

Visualization dashboards in the intensive care unit (ICU) were able to decrease time spent gathering data and completing tasks, while reducing errors, according to recent research. They also improved situational awareness, guideline compliance and navigation.

Infection prevention programs need 66% more staffing

Infection preventionist and relative support staffing levels need to be 31 to 66 percent higher for healthcare organizations to sustain an effective infection prevention program, according to a study published in the May 2018 issue of the American Journal of Infection Control.

Thumbnail

UNC Health Care CEO Bill Roper to step down next year

Roper first joined the university as dean of its School for Public Health in 1997. He was then promoted to CEO of the healthcare system, dean of the medical school and vice chancellor for medical affairs in 2004.

Thumbnail

‘Right-to-try’ sponsor: Law is meant to diminish the FDA’s power

Johnson said if FDA Commissioner Scott Gottlieb intends to limit the reach of the law through new FDA rules, that would go against his intent in writing the legislation.

Thumbnail

CHS finalizes sale of 3 Tennessee hospitals

Community Health Systems’ selling spree continues, this time in its home state in Tennessee, as the for-profit hospital giant finalized the sale of three hospitals to West Tennessee Healthcare, a public, not-for-profit system.

Thumbnail

Online consumer ratings of healthcare providers are highly skewed

This shouldn't be too surprising, but you can't always believe what you read on the internet. The online consumer ratings of healthcare providers are highly skewed, differ by specialty and fall within narrow margins, according to a study published May 9 in the Journal of Medical Internet Research.

Thumbnail

Senator promotes price transparency, short-term insurance in healthcare plan

Sen. Bill Cassidy, MD, R-Louisiana, released a series of new healthcare proposals that would expand insurance which doesn’t comply with the Affordable Care Act, along with new ideas on requiring price transparency and incentivizing care settings that are less expensive than hospitals.

Thumbnail

AMA touts leadership combating opioid epidemic as story labels group a barrier to reforms

The American Medical Association (AMA) released a report on May 31 detailing how “physician leadership” has led to progress fighting the epidemic of opioid abuse and addiction. Just two days earlier, however, a story published by the Daily Beast labeled the AMA as a main roadblock to Congress addressing the prescription of opioids.

Displaying 3489 - 3496 of 6654

Around the web

Cardiovascular Business
Q&A: Why are cardiovascular devices involved in so many recalls? FDA policies may be to blame

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup